PT  - JOURNAL ARTICLE
ED  - ,
TI  - Appetite suppressants reassessed
AID  - 10.1136/dtb.20.9.35
DP  - 1982 Apr 30
TA  - Drug and Therapeutics Bulletin
PG  - 35--36
VI  - 20
IP  - 9
4099  - http://dtb.bmj.com/content/20/9/35.short
4100  - http://dtb.bmj.com/content/20/9/35.full
SO  - Drug Ther Bull1982 Apr 30; 20
AB  - Since we last discussed appetite suppressants1 their limitations have become better understood, and this prompts a reassessment of their place in the management of obesity. Centrally acting appetite suppressant drugs or anorectics reduce physiological hunger by an action on the brain, presumably interfering with the pathways concerned in the regulation of food intake.2 Methylcellulose (Cellucon, Celevac, Cologel) and sterculia (Prefil) act by filling the stomach and are less effective clinically but are safe.3 This article discusses only those drugs with central actions.